Status:
UNKNOWN
Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis
Lead Sponsor:
General Hospital of Chinese Armed Police Forces
Collaborating Sponsors:
Xinjiang Armed Police Corps Hospital
Taian Hospital of Traditional Chinese Medicine
Conditions:
Other Surgical Procedures
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Mainstream of current treatment of liver cirrhosis is liver transplantation, but there are high cost, risk and immune rejection and other issues. Umbilical cord mesenchyma stem cell with self-and dire...
Detailed Description
This study included three research centers, each center were carried out 25 cases of liver cirrhosis in patients with stem cell transplantation. All the selection and exclusion criteria are same, data...
Eligibility Criteria
Inclusion
- Clinical diagnosis of liver cirrhosis;
- Without hepatic encephalopathy;
- No ascites or have easily dissipated ascites;
- Value of bilirubin is less than 100;
- Value of albumin is greater than 16 g / L;
- Prothrombin time is less than 21 seconds;
Exclusion
- Severe cardiovascular disease, and immunocompromised patients;
- Patients with localized lesions affecting graft infection;
- Coagulation disorders;
- Liver nodules more than 2cm or Liver cancer
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01491165
Start Date
December 1 2011
End Date
June 1 2014
Last Update
October 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yihua An
Beijing, China